LUPICA, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 2.004
AS - Asia 1.370
EU - Europa 1.273
Continente sconosciuto - Info sul continente non disponibili 240
SA - Sud America 181
AF - Africa 29
OC - Oceania 2
Totale 5.099
Nazione #
US - Stati Uniti d'America 1.876
SG - Singapore 503
RU - Federazione Russa 495
IT - Italia 305
CN - Cina 286
HK - Hong Kong 148
BD - Bangladesh 142
BR - Brasile 141
VN - Vietnam 107
PL - Polonia 97
DE - Germania 96
CA - Canada 74
FR - Francia 70
GB - Regno Unito 53
JP - Giappone 41
FI - Finlandia 37
IN - India 36
NL - Olanda 30
SE - Svezia 19
MX - Messico 18
KR - Corea 16
IQ - Iraq 14
AT - Austria 13
TR - Turchia 13
AR - Argentina 12
ES - Italia 12
PK - Pakistan 12
ZA - Sudafrica 12
IE - Irlanda 11
JM - Giamaica 10
CO - Colombia 8
PH - Filippine 8
SA - Arabia Saudita 8
EC - Ecuador 7
BE - Belgio 6
CR - Costa Rica 5
MA - Marocco 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
LB - Libano 4
MY - Malesia 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
CI - Costa d'Avorio 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
LT - Lituania 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
VE - Venezuela 3
AM - Armenia 2
AU - Australia 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
RO - Romania 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
NP - Nepal 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SV - El Salvador 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.861
Città #
Singapore 327
Ashburn 304
Dallas 301
San Jose 195
Hong Kong 133
Council Bluffs 93
Moscow 85
Zgierz 81
New York 79
Los Angeles 63
Palermo 62
Chandler 59
Hefei 53
Beijing 46
Hanoi 45
The Dalles 43
Tokyo 41
Lauterbourg 39
Boardman 26
Rome 25
Fairfield 24
Buffalo 23
Orem 23
São Paulo 23
Toronto 23
Ho Chi Minh City 22
Milan 22
Helsinki 21
Frankfurt am Main 20
Chicago 19
Falkenstein 16
Ludwigshafen am Rhein 16
Montreal 16
Lappeenranta 15
Nuremberg 15
Santa Clara 14
Stockholm 14
Amsterdam 13
Denver 13
London 13
Johannesburg 12
Medford 12
Warsaw 12
Central 11
Phoenix 11
Atlanta 10
Dublin 10
Mexico City 10
Mumbai 10
Poplar 10
Bari 9
Vienna 9
Houston 8
Altamura 7
Chennai 7
Lawrence 7
Princeton 7
Redondo Beach 7
Seattle 7
Brooklyn 6
Columbus 6
Da Nang 6
Elk Grove Village 6
Manchester 6
Naples 6
Rio de Janeiro 6
Turin 6
Vancouver 6
Washington 6
Ankara 5
Belgrade 5
Boston 5
Cambridge 5
Guangzhou 5
Pune 5
Salt Lake City 5
San Francisco 5
San José 5
Wilmington 5
Bexley 4
Bratislava 4
Brussels 4
Cagliari 4
Charlotte 4
Haiphong 4
Hải Dương 4
Kingston 4
Managua 4
Munich 4
Ningbo 4
Ottawa 4
Paris 4
Shenzhen 4
Tashkent 4
Trento 4
Wroclaw 4
Abidjan 3
Amman 3
Basra 3
Brasília 3
Totale 2.831
Nome #
Evidence-based guidelines for the pharmacological treatment of migraine, summary version 187
Adherence and Reactogenicity to Vaccines against SARS-COV-2 in 285 Patients with Neuropathy: A Multicentric Study 177
Evidence-based guidelines for the pharmacological treatment of migraine 174
Inherited neuromuscular disorders: Which role for serum biomarkers? 172
Median-to-ulnar nerve communication in carpal tunnel syndrome: An electrophysiological study 165
OnabotulinumtoxinA Modulates Visual Cortical Excitability in Chronic Migraine: Effects of 12-Week Treatment 156
Insomnia and Migraine: A Missed Call? 153
Clinical and Neurophysiological Follow-Up of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Subcutaneous Immunoglobulins: A Real-Life Single Center Study 150
Aromatic L-Amino Acid Decarboxylase Deficiency: A Genetic Screening in Sicilian Patients with Neurological Disorders 150
A novel compound heterozygous mutation in PYGM gene associated with McArdle's disease 150
Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome 149
Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort 144
Patisiran Enhances Muscle Mass after Nine Months of Treatment in ATTRv Amyloidosis: A Study with Bioelectrical Impedance Analysis and Handgrip Strength 143
Genetic and Clinical Spectrum of Limb–Girdle Muscular Dystrophies in Western Sicily 139
Autosomal recessive spino-cerebellar ataxia type 10 (SCAR10): clinical presentation associated with c.289delA ANO10 gene variant 134
Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic 131
AChR-seropositive myasthenia gravis in muscular dystrophy: diagnostic pitfalls and clinical management challenges 129
Hirayama disease: Nosological classification and neuroimaging clues for diagnosis 126
Motor Conduction Studies and Handgrip in Hereditary TTR Amyloidosis: Simple Tools to Evaluate the Upper Limbs 124
Evaluation of disease progression and response to therapy in a cohort of late childhood/adulthood SMA patients: Is there room for new markers? 121
Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis 119
Comorbidity in myasthenia gravis: multicentric, hospital-based, and controlled study of 178 Italian patients 118
Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows 117
Physical Activity in Patients with Neuromuscular Disease Three Years after COVID-19, a Longitudinal Survey: The After-Effects of the Quarantine and the Benefits of a Return to a Healthier Life-Style 117
The Role of Brain Plasticity in Neuromuscular Disorders: Current Knowledge and Future Prospects 116
Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis 114
The Clinical Relevance of Artificial Intelligence in Migraine 111
Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis 110
Rituximab in AChR subtype of myasthenia gravis: Systematic review 109
Effects of a Single Session of OnabotulinumtoxinA Therapy on Sleep Quality and Psychological Measures: Preliminary Findings in a Population of Chronic Migraineurs 108
Non-pharmacological treatment of hereditary spastic paraplegia: a systematic review 106
New-onset headache following COVID-19: An Italian multicentre case series 105
Usefulness and Clinical Impact of Whole-Body MRI in Detecting Autoimmune Neuromuscular Disorders 99
The mysterious connection between migraine and dementia: epiphenomenon or causation? Special considerations 99
Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study 98
The Mitochondrial tRNASer(UCN) Gene: A Novel m.7484A>G Mutation Associated with Mitochondrial Encephalomyopathy and Literature Review 94
Challenges in the identification of nocturnal respiratory events in adult patients affected by spinal muscular atrophy 89
Neurological vertigo in the emergency room in pediatric and adult age: systematic literature review and proposal for a diagnostic algorithm 82
Sensory neuropathy in amyotrophic lateral sclerosis: a systematic review 75
Multiple respiratory assessment and thresholds for noninvasive ventilation in adult patients with spinal muscular atrophy 71
Spectrum of sleep‐disordered breathing and quality of sleep in adolescent and adult patients with spinal muscular atrophy 50
Evaluating effects of risdiplam in adults with spinal muscular atrophy: a monocentric study 18
Totale 5.099
Categoria #
all - tutte 21.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022107 0 0 4 29 1 2 4 5 2 10 21 29
2022/2023229 7 33 20 10 12 19 2 24 20 33 43 6
2023/2024388 11 12 10 15 34 85 49 18 11 8 76 59
2024/2025787 15 21 20 109 40 32 51 58 40 112 133 156
2025/20263.251 249 52 483 261 311 459 373 292 238 148 181 204
2026/2027311 115 141 55 0 0 0 0 0 0 0 0 0
Totale 5.099